Overview

The 25th annual Diabetes Day: Therapeutics, Technology and Surgery is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include:

For over twenty five years, Cleveland Clinic has been at the forefront of diabetes treatment, research and education.  Its world class faculty has designed Diabetes Therapeutics, Technology and Surgery to provide up-to-date reviews of management strategies and research on the complications of this disease.  It includes a detailed analysis of therapeutic options applicable to type 1 and type 2 diabetes, as well as their complications

Diabetes Day, Therapeutics, Technology and Surgery, is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include a review of therapeutic options to manage both type 1 and 2 diabetes and the complications, including a pump update, dual hormone therapies, sulfonylureas, GLP1 agonists, metformin, and the role of exercise and fasting. New this year is a discussion of the pathophysiologic impact of COVID-19. The goal of this course is to increase practitioners’ competence and clinical performance to treat diabetes and its complications and, ultimately, to improve patient outcomes.

Attendees will be able to:

• Describe the efficacy and side effects of therapeutic innovations for type 1 diabetes, including closed-loop insulin pumps, dual hormone therapy, and glucagon.
• Compare the effectiveness of new and emerging therapies for both type 1 and 2 diabetes.
• Critically appraise the impact of bariatric surgery on patients with type 2 diabetes.
• Describe options for treating children with type 2 diabetes.
• Compare the data on effectiveness of diets and exercise in diabetes strategies.
• Summarize research defining the pathophysiologic impact of nonalcoholic steatohepatitis.
• Describe how COVID-19 affects the progression of diabetes in infected patients

Who should attend?

This activity is designed for primary care physicians, endocrinologists, diabetes educators, pharmacists, nurses, nurse practitioners, physician assistants, and other health care professionals who care for patients with diabetes.